---
created: 2025-04-13
updated: 2025-04-13T10:52
id: NQ>s&_};?g
specialty: immuno
specialty_id: 118
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::12-immunology::03-pharm::02-immunosuppressive-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::01-immunosuppressants
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::01-immunosuppressants::sirolimus/rapamycin
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::01-immunology::03-sirolimus
  - "source/ak-step1-v11:": 
  - theme/pixorize::01-immunology::09-immunosuppressants::03-sirolimus-(rapamycin)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::immunology-&-biochemistry-pharmacology::immuno-suppressives::transplant-rejection-prophylaxis
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
Sirolimus works by binding **FKBP**, which inhibits the **mTOR::specific signal** signalling complex involved in cell growth

---

# Answer
- Important, when FKBP is bound by Tacrolimus the complex inhibits calcineurin, BUT when bound by Sirolimus the complex inhibits the mTOR Complex I       - mTORC1 is a complex of mTOR and various adaptor proteins that will activate different pathways based on different intracellular cues detected by the complex (i.e. Certain cues will stimulate cell growth, other cues will stimulate autophagy, etc.)